Trichomoniasis in a postmenopausal woman cured after discontinuation of estrogen replacement therapy

Sexually Transmitted Diseases

Volumn 24, Issue 9, 1997, Pages 543-545

  Sharma, Roopali ^a   Pickering, Joyce ^a   Mccormack, William M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; METRONIDAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; ECZEMA; ESTROGEN THERAPY; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PARASITE CULTIVATION; POSTMENOPAUSE; TOPICAL DRUG ADMINISTRATION; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ANTITRICHOMONAL AGENTS; DRUG ERUPTIONS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; METRONIDAZOLE; MIDDLE AGED; POSTMENOPAUSE; TRICHOMONAS VAGINITIS; VAGINA;

EID: 0030693389     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199710000-00009     Document Type: Article

References (15)

1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165:1168-1176.
2. Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 1990; 163:510-514.
3. Krieger JN. New sexually transmitted diseases treatment guidelines. J Urol 1995; 154:209-213.
4. Roe FJC. Metronidazole: review of uses and toxicity. J Antimicrob Chemother 1977; 3:205-212.
5. MicroMedex Inc., Metronidazole - Drug Evaluation Monograph, Vol 86, 1995.
6. Muller M, Lossick JG, Gorrell TE. In-vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex Transm Dis 1988; 15:17-23.
7. Wang CC, Cheng HW. Salvage of pyrimidine nucleosides by Trichomonas vaginalis. Mol Biochem Parasitol 1984; 10:171-184.
8. Brown MT. Trichomoniasis. Practitioner 1972; 209:639-644.
9. Ford LC, Hammill HA, DeLange RJ, et al. Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones. Am J Obstet Gynecol 1987; 156:1119-1121.
10. Cappuccinelli P, Lattes C, Cagliani I, Negro Ponzi A. Features of intravaginal Trichomonas vaginalis infection in the mouse and the effect of oestrogen treatment and immunodepression. G Batteriol Virol Immunol 1974; 67:31-40.
11. Maestrone G, Semar R. Experimental intravaginal infection with Trichomonas foetus in guinea pigs. Chemotherapy 1967; 12:137-145.
12. Azuma T. A study of the parasitizing condition of Trichomonas vaginalis with special reference to the relationship between estrogen and the growth of Trichomonas vaginalis. J Jap Obstet Gynec Soc 1968; 15:168-172.
13. Stein IF, Cope EJ. Trichomonas vaginalis (Donné). Am J Obstet Gynecol 1933; 25:819-825.
14. Martinotti MG, Savoia D. Effect of some steroid hormones on the growth of Trichomonas vaginalis. G Batteriol Virol Immunol 1985; 78:52-59.
15. al-Salihi FL, Curran JP, Wang J. Neonatal Trichomonas vaginalis: report of three cases and review of the literature. Pediatrics 1974; 53:196-200.